Monopar Therapeutics (MNPR) Change in Acquisitions & Divestments (2023 - 2025)

Monopar Therapeutics (MNPR) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $16.1 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $16.1 million; the trailing twelve-month figure through Dec 2025 stood at $23.7 million (up 2304.31% YoY), and the FY2025 full-year result was $23.7 million, up 2304.31% from the prior year.
• Change in Acquisitions & Divestments advanced to $16.1 million in Q4 2025, from $3.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $16.1 million in Q4 2025 to a low of $985730.0 in Q3 2024.
• A 3-year average of $4.2 million and a median of $3.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments sank 66.66% in 2024 and surged 265.21% in 2025, its largest moves.
• Tracing MNPR's Change in Acquisitions & Divestments over 3 years: stood at $3.0 million in 2023, then plunged by 66.71% to $985730.0 in 2024, then jumped by 1533.31% to $16.1 million in 2025.
• Business Quant data shows MNPR's Change in Acquisitions & Divestments at $16.1 million in Q4 2025, $3.6 million in Q3 2025, and $2.4 million in Q2 2025.